Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Multi-Omics Study Reveals Pathway-Level Insights and Predictive Biomarkers in pediatric TB.

medRxiv : the preprint server for health sciences·2026

Same author

Corrigendum: <i>Corynebacterium drakensteinense</i> sp. nov., isolated from the nasopharynx of a healthy South African infant.

International journal of systematic and evolutionary microbiology·2026

Same author

Association of maternal antenatal distress with child amygdala-prefrontal cortex functional connectivity at 2-3 years in a South African birth cohort study.

Brain research bulletin·2026

Same author

Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort.

Wellcome open research·2026

Same author

Resting-state functional connectivity in HIV - Findings from the ENIGMA HIV working group.

Psychiatry research. Neuroimaging·2026

Same author

Breastfeeding association with DNA methylation in the pregnancy and childhood epigenetics (PACE) consortium.

Clinical epigenetics·2026

Same journal

Molluscum Contagiosum Treatments in Children: A Systematic Review with Network Meta-Analysis.

Paediatric drugs·2026

Same journal

Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED ohort).

Paediatric drugs·2026

Same journal

Epinephrine Underuse for Anaphylaxis in Infants and Toddlers: A Practical Review for Pediatricians.

Paediatric drugs·2026

Same journal

Risks of Undertreatment and Overtreatment in Pediatric Inflammatory Bowel Disease: Navigating the Balance.

Paediatric drugs·2026

Same journal

Discontinuing Colchicine in Pediatric Familial Mediterranean Fever: Real-Life Experience from a Long-Term Follow-Up Cohort.

Paediatric drugs·2026

Same journal

Sirolimus Therapy and Dyslipidemia in Neonates and Infants: A Retrospective Cohort and Pharmacovigilance Analysis.

Paediatric drugs·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 18, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Challenges in treating pediatric asthma in developing countries.

Heather J Zar¹, Michael E Levin

¹Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa. heather.zar@uct.ac.za

Paediatric Drugs

|September 18, 2012

Summary

This summary is machine-generated.

Childhood asthma management is challenging in low-income countries due to diagnosis, access, and treatment barriers. Improving healthcare education and affordable therapies are crucial for effective asthma control in children.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Experiment Videos

Last Updated: May 18, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

Pediatric Pulmonology
Global Health

Background:

Childhood asthma is a prevalent chronic respiratory disease, with increasing prevalence and severity in low- and middle-income countries (LMICs).
Effective asthma management is hindered by numerous challenges in LMICs, including under-diagnosis, limited access to care, and insufficient healthcare worker training.

Purpose of the Study:

To identify and address the multifaceted challenges in providing optimal childhood asthma management in resource-limited settings.
To highlight the critical need for accessible and affordable inhaled therapies and educational interventions.

Main Methods:

The study synthesizes existing literature and clinical observations on childhood asthma management in LMICs.
It analyzes barriers related to diagnosis, treatment accessibility, healthcare provider education, public awareness, and socioeconomic factors.

Main Results:

Key challenges include under-diagnosis, poor access to affordable inhaled corticosteroids and bronchodilators, and inadequate patient/provider education.
A low-cost plastic bottle spacer demonstrates effectiveness for metered-dose inhaler use but requires integration into educational programs.
Socioeconomic and structural barriers significantly impede optimal asthma treatment for children.

Conclusions:

Implementing international asthma guidelines in LMICs faces significant hurdles, particularly concerning drug affordability and accessibility.
Culturally and linguistically appropriate educational programs for healthcare personnel and the public are essential for guideline implementation.
Addressing socioeconomic and systemic barriers is vital to improve childhood asthma outcomes in resource-limited settings.